NAGASE & CO., LTD.

Established in 1832 with net sales of US$7 billion, this Japan-based trading house includes manufacturing companies for finished dosage forms and excipients. Its subsidiary Nagase Medicals Co., Ltd. is a sterile FDF manufacturer dedicated to producing injectables and liposomal dosage forms specializing in oncology, while its subsidiary Hayashibara Co., Ltd. is the world's largest commercial manufacturer of saccharide-based excipients, including trehalose, maltose and pullulan.